Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C H activation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel iron-catalyzed route for pyrrolo[1,2-a]indole derivatives offers mild conditions and high yields, ensuring reliable supply chain for pharma intermediates.
Novel cobalt-catalyzed carbonylation route for indolo[1,2-a]quinazolin-6(5H)-ones. High efficiency, low cost, scalable process for pharmaceutical intermediates.
Novel rhodium-catalyzed method ensures high purity and yield for organic luminescent materials manufacturing with scalable supply chain solutions.
Patent CN115636829B reveals efficient Rh-catalyzed synthesis for high-purity organic luminescent materials with scalable cost reduction potential.
Patent CN115925692A details Rh-catalyzed C-H activation for trifluoromethyl enamines. High yields, scalable process for drug discovery.
Patent CN118619879A reveals a Rh-catalyzed route for trifluoromethyl enaminones. This method offers high purity, scalability, and cost-effective supply chain solutions for global pharmaceutical manufacturers.
Novel Pd-catalyzed C-H activation method for 2-perfluoroalkyl indoles. Green oxidation, high regioselectivity, scalable for pharmaceutical intermediates.
Novel Rh-catalyzed method for benzimidazo[1,2-a]quinolines using ionic liquids. High yield, additive-free process for pharma intermediates.
Patent CN106631982A enables efficient carbazole synthesis. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing for global partners.
Patent CN113620795B details a Rh-catalyzed C-H activation route to benzocycloheptenones. This method offers mild conditions, high yields, and scalable production for pharmaceutical intermediates.
Patent CN118619879A reveals a novel Rhodium-catalyzed route for high-purity trifluoromethyl enaminones, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN115636829B details rhodium-catalyzed synthesis for organic luminescent materials offering significant supply chain stability and cost optimization for electronic chemical manufacturing.
Patent CN112209867B details a robust Rh-catalyzed C-H activation route for 2-alkynyl indoles, offering cost reduction in API manufacturing and scalable production.
Patent CN108658841B reveals a mild Rh-catalyzed route to carbazoles from boronic acids and azides, offering cost reduction in electronic chemical manufacturing.
Novel Rh-catalyzed C-H activation for trifluoromethyl enaminones. High purity pharmaceutical intermediates with scalable cost reduction.
Patent CN117417339A details Rhodium catalyzed synthesis offering high purity and scalable production for global pharmaceutical intermediate supply chains.
Patent CN108690007B details a transition metal-catalyzed C-H coupling method using ionic liquids for efficient ortho-cyanation, offering significant cost reduction in API manufacturing.
Patent CN114409714B discloses a Pd-catalyzed method for 1 3-disubstituted planar chiral metallocenes offering high ee values and scalable manufacturing for pharmaceutical intermediates.
Patent CN118619879A reveals Rh-catalyzed route for high-purity intermediates. This method offers substantial cost reduction and supply chain reliability for global pharmaceutical manufacturers seeking scalable solutions.
Patent CN109879792B details a Rh-catalyzed oxidative Heck reaction for isoindoles. Offers efficient route for pharma intermediates with improved atom economy.